Cargando…
UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
We previously showed that UBE2C mRNA expression is significantly associated with poor prognosis only in patients with hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)– breast cancer. In this study, we further reanalyzed the correlation between UBE2C mRNA expression and clinical...
Autores principales: | Kim, Yu-Jin, Lee, Gyunghwa, Han, Jinil, Song, Kyoung, Choi, Joon-Seok, Choi, Yoon-La, Shin, Young Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989552/ https://www.ncbi.nlm.nih.gov/pubmed/32039034 http://dx.doi.org/10.3389/fonc.2019.01574 |
Ejemplares similares
-
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017) -
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2018) -
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2019) -
Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer
por: Zhu, Xuan, et al.
Publicado: (2020) -
Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer
por: Zhu, Xuan, et al.
Publicado: (2020)